Treatment with Mirvetuximab-Soravtansin-first clinical experience in advanced ovarian cancer in a comprehensive cancer center. - Schwörer I; Huwer S; Rautenberg B; Neubauer J; Juhasz-Böss I; Jung L (Frontiers in oncology, 2026)